Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Theca Cells | 5 | 2012 | 18 | 1.700 |
Why?
|
| Chorionic Gonadotropin | 3 | 2012 | 130 | 1.120 |
Why?
|
| Small Molecule Libraries | 4 | 2022 | 169 | 0.670 |
Why?
|
| Mammary Glands, Animal | 2 | 2019 | 533 | 0.660 |
Why?
|
| DNA | 7 | 2023 | 2693 | 0.590 |
Why?
|
| Insulin | 2 | 2012 | 1454 | 0.510 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2018 | 494 | 0.500 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 701 | 0.500 |
Why?
|
| Tamoxifen | 1 | 2018 | 876 | 0.470 |
Why?
|
| Multiprotein Complexes | 2 | 2012 | 395 | 0.460 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 2045 | 0.430 |
Why?
|
| Luteinizing Hormone | 1 | 2012 | 165 | 0.420 |
Why?
|
| Androgens | 2 | 2012 | 511 | 0.410 |
Why?
|
| beta-Lactamase Inhibitors | 2 | 2023 | 52 | 0.400 |
Why?
|
| Cyclic AMP | 1 | 2010 | 358 | 0.350 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2009 | 32 | 0.350 |
Why?
|
| Transcriptome | 1 | 2018 | 1859 | 0.340 |
Why?
|
| beta-Lactamases | 4 | 2024 | 179 | 0.340 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2012 | 1546 | 0.340 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 2359 | 0.340 |
Why?
|
| Escherichia coli | 3 | 2024 | 1203 | 0.320 |
Why?
|
| Signal Transduction | 4 | 2023 | 11965 | 0.320 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 3552 | 0.270 |
Why?
|
| Proteins | 2 | 2019 | 1963 | 0.260 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2012 | 2063 | 0.240 |
Why?
|
| Sirolimus | 3 | 2012 | 814 | 0.230 |
Why?
|
| Rats | 5 | 2012 | 6086 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 2054 | 0.220 |
Why?
|
| Copper | 1 | 2023 | 165 | 0.210 |
Why?
|
| Phosphoproteins | 3 | 2012 | 1152 | 0.210 |
Why?
|
| Ribosomal Protein S6 | 2 | 2012 | 46 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8873 | 0.210 |
Why?
|
| Cells, Cultured | 4 | 2018 | 5637 | 0.210 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2012 | 265 | 0.200 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2012 | 131 | 0.200 |
Why?
|
| Egg Shell | 1 | 2020 | 2 | 0.200 |
Why?
|
| Corchorus | 1 | 2020 | 2 | 0.200 |
Why?
|
| Androstenedione | 2 | 2012 | 18 | 0.200 |
Why?
|
| Composite Resins | 1 | 2020 | 5 | 0.200 |
Why?
|
| Glass | 1 | 2020 | 30 | 0.200 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2012 | 36 | 0.190 |
Why?
|
| Polyesters | 1 | 2020 | 53 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2012 | 1265 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 2992 | 0.190 |
Why?
|
| Nanostructures | 1 | 2020 | 94 | 0.180 |
Why?
|
| Hydrocarbons, Halogenated | 1 | 2019 | 5 | 0.180 |
Why?
|
| Phosphorylation | 3 | 2012 | 4804 | 0.170 |
Why?
|
| Nitro Compounds | 1 | 2019 | 23 | 0.170 |
Why?
|
| Boron Compounds | 1 | 2019 | 59 | 0.170 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2023 | 486 | 0.170 |
Why?
|
| Amines | 1 | 2019 | 85 | 0.170 |
Why?
|
| Gene Silencing | 2 | 2012 | 837 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 17 | 0.160 |
Why?
|
| Animals | 10 | 2023 | 59536 | 0.160 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2019 | 518 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2010 | 5270 | 0.140 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2012 | 116 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 1217 | 0.130 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 2216 | 0.130 |
Why?
|
| Binding Sites | 1 | 2019 | 2171 | 0.130 |
Why?
|
| Catalysis | 3 | 2020 | 250 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2012 | 1678 | 0.130 |
Why?
|
| Cell Proliferation | 3 | 2012 | 7226 | 0.130 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 1029 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 1064 | 0.120 |
Why?
|
| Peptides | 1 | 2020 | 1479 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 15694 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 2314 | 0.110 |
Why?
|
| Carrier Proteins | 2 | 2012 | 2022 | 0.110 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2012 | 7 | 0.110 |
Why?
|
| Colforsin | 1 | 2012 | 59 | 0.110 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 840 | 0.110 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2012 | 94 | 0.110 |
Why?
|
| Enzyme Induction | 1 | 2012 | 249 | 0.110 |
Why?
|
| Catalytic Domain | 2 | 2024 | 303 | 0.110 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2012 | 194 | 0.100 |
Why?
|
| Female | 9 | 2023 | 141928 | 0.100 |
Why?
|
| Cattle | 1 | 2012 | 783 | 0.100 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 2265 | 0.100 |
Why?
|
| Cyclin D3 | 1 | 2010 | 23 | 0.100 |
Why?
|
| Gene Library | 2 | 2023 | 294 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 371 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 2086 | 0.090 |
Why?
|
| Mice, Nude | 1 | 2018 | 4307 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2012 | 1764 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 2291 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2012 | 413 | 0.090 |
Why?
|
| Aminoglutethimide | 1 | 2009 | 12 | 0.090 |
Why?
|
| Hydroxycholesterols | 1 | 2009 | 16 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3821 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1077 | 0.090 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2009 | 44 | 0.090 |
Why?
|
| Genomics | 1 | 2019 | 2738 | 0.080 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 129 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 4053 | 0.080 |
Why?
|
| Metformin | 1 | 2012 | 378 | 0.080 |
Why?
|
| Ovary | 1 | 2012 | 668 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 803 | 0.080 |
Why?
|
| Cyclin D1 | 1 | 2010 | 576 | 0.080 |
Why?
|
| RNA Interference | 1 | 2012 | 1408 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 280 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 5159 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 4638 | 0.070 |
Why?
|
| Cholesterol | 1 | 2009 | 658 | 0.070 |
Why?
|
| Mice | 3 | 2023 | 34495 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 2307 | 0.060 |
Why?
|
| beta-Lactams | 1 | 2023 | 53 | 0.060 |
Why?
|
| Sphingomyelins | 1 | 2023 | 33 | 0.060 |
Why?
|
| Alloys | 1 | 2023 | 32 | 0.060 |
Why?
|
| Penicillins | 1 | 2023 | 143 | 0.060 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2023 | 19 | 0.060 |
Why?
|
| Electrodes | 1 | 2023 | 116 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2022 | 227 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 1823 | 0.050 |
Why?
|
| Semen | 1 | 2022 | 90 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2024 | 644 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 342 | 0.050 |
Why?
|
| Powders | 1 | 2020 | 23 | 0.050 |
Why?
|
| Methacrylates | 1 | 2020 | 21 | 0.050 |
Why?
|
| Tensile Strength | 1 | 2020 | 73 | 0.050 |
Why?
|
| Filtration | 1 | 2020 | 92 | 0.050 |
Why?
|
| Materials Testing | 1 | 2020 | 116 | 0.050 |
Why?
|
| Elasticity | 1 | 2020 | 156 | 0.050 |
Why?
|
| Surface Properties | 1 | 2020 | 180 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 994 | 0.050 |
Why?
|
| Cyclization | 1 | 2020 | 21 | 0.050 |
Why?
|
| Buffers | 1 | 2020 | 44 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2010 | 6150 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 368 | 0.050 |
Why?
|
| Nanotechnology | 1 | 2020 | 137 | 0.050 |
Why?
|
| Ligands | 1 | 2022 | 995 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2022 | 324 | 0.040 |
Why?
|
| Palladium | 1 | 2019 | 56 | 0.040 |
Why?
|
| Oxygen | 1 | 2023 | 754 | 0.040 |
Why?
|
| Time Factors | 1 | 2012 | 12926 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2009 | 2819 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2019 | 515 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1945 | 0.040 |
Why?
|
| Humans | 5 | 2023 | 261506 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 278 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 503 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 848 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 586 | 0.020 |
Why?
|
| Mutation | 1 | 2024 | 15179 | 0.010 |
Why?
|
| Male | 1 | 2022 | 123000 | 0.010 |
Why?
|